Nexity

Adapt. Once again.

23/10/26 -"Nexity reports anemic bookings for Q3 26. The company has announced adjustment measures, though these remain short on detail for the time being. Nexity has ruled out a capital increase in the short ..."

PDF page sample
Pages
83
Language
English
Published on
23/10/26
Download
You may also be interested by these reports :
23/10/26
URW identifies “continued operating momentum” and remains very confident in its 2026 outlook. We do not detect any note of caution from management ...
23/10/26
Q3 26 communications remain focused on the strategic tie-up with ARGAN, slated for 2027. WDP’s economic performance continues to hold up well, even ...
23/10/26
Nexity reports anemic bookings for Q3 26. The company has announced adjustment measures, though these remain short on detail for the time being. ...
22/10/26
Organic decline continued in Q3 26, albeit at a contained level. Despite divestments, debt remains high. Castellum continues to prioritize share ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO